Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

32.47
+0.24000.74%
Post-market: 32.510.0400+0.12%19:30 EDT
Volume:1.39M
Turnover:45.31M
Market Cap:19.97B
PE:25.67
High:32.70
Open:32.45
Low:32.27
Close:32.23
52wk High:35.43
52wk Low:23.62
Shares:615.00M
Float Shares:604.00M
Volume Ratio:1.06
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.54
ROE:14.00%
ROA:8.79%
PB:3.35
PE(LYR):21.13

Loading ...

Genmab's Darzalex Generates $4.21 Billion in Q2 Net Trade Sales

MT Newswires Live
·
Jul 15

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

TIPRANKS
·
Jul 15

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

TIPRANKS
·
Jul 13

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 11

Genmab A/S Stock Falls Wednesday, Outperforms Market

Dow Jones
·
Jul 09

Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook

MT Newswires Live
·
Jul 07

Genmab Secures EU Approval for Drug Combination Intended for Relapsed or Refractory Follicular Lymphoma

MT Newswires Live
·
Jul 07

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 04

Genmab is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 02

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 02

Abbvie, Genmab Blood-cancer Drug Has Competitive Profile

Dow Jones
·
Jun 30

Investors See European Pharma Stocks as Funding Source for AI Trades

Dow Jones
·
Jun 30

Guggenheim Reaffirms Their Buy Rating on Genmab (GMAB)

TIPRANKS
·
Jun 30

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
Jun 30

Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial

Dow Jones
·
Jun 30

Abbvie, Genmab's Lymphoma Treatment Meets Primary Endpoint in Phase 3 Trial

Dow Jones
·
Jun 30

Genmab announces topline results from EPCORE DLBCL-4 trial

TIPRANKS
·
Jun 30

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jun 30